226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.
Poster Session: Antimicrobial Novel Agents
Stephen Hawser, PhD
CEO
IHMA Europe
Monthey, Valais, Switzerland
Nimmi Kothari, PhD
IHMA
Monthey, Valais, Switzerland
Federica Monti, PhD
IHMA
Monthey, Valais, Switzerland
Tony Hodges, MD
La Jolla Therapeutics
Waltham, Massachusetts, United States
Kristie Zappas, PhD
Innoviva Specialty Therapeutics, Inc.
Waltham, Massachusetts, United States